Drug Free Solution
DSOL · OTC
Price unavailable right now.
No price history for this range.
Key indicators
DSOL profitability and balance sheet ratios
EPS -$0.0034 in Feb 2014, against -$0.004 a year earlier.
| Period | EPS |
|---|---|
| Feb 2012 | -$0.0078 |
| May 2012 | -$0.0027 |
| Aug 2012 | -$0.0048 |
| Feb 2013 | -$0.004 |
| May 2013 | -$0.0062 |
| Aug 2013 | -$0.0006 |
| Nov 2013 | -$0.0037 |
| Feb 2014 | -$0.0034 |
Income statement
No financial statements are reported for Drug Free Solution.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Aug 2013 | Nov 2013 | Feb 2014 |
|---|---|---|---|
| Total assets | $0.0M | $0.0M | $0.1M |
| Total liabilities | $0.1M | $0.3M | $0.4M |
| Shareholder equity | −$0.1M | −$0.2M | −$0.3M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.